Freemont Management »

Amneal Pharmaceuticals shares owned by Freemont Management

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Freemont Management from 13F filings

Historical chart of Freemont Management investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Freemont Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Freemont Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.0M 320k 12.43

More positions owned by Freemont Management

NVIDIA Corporation Common Stock (NVDA)
Arista Networks Common Stock (ANET)
Alphabet Class A Common Stock (GOOGL)
Toast ETD Equity Option Call Option
Take-Two Interactive Software ETD Equity Option Call Option
Targa Resources Corp. ETD Equity Option Call Option
Broadcom Common Stock (AVGO)
IQVIA Holdings Common Stock (IQV)
Cadence Design Systems Common Shares (CDNS)
Fabrinet Ordinary Shares (FN)
GE Vernova Common Stock (GEV)
Tesla Common Stock (TSLA)
Apple Common Stock (AAPL)
MACOM Technology Solutions Holdings Common Stock (MTSI)
Waters Corporation Common Stock (WAT)

View all positions for Freemont Management

Top funds holding Amneal Pharmaceuticals

BlackRock
Vanguard Group
Tpg Gp A
Vanguard Portfolio Management
Rubric Capital Management
Vanguard Capital Management
Dimensional Fund Advisors
Morgan Stanley
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Nuveen
Invesco
Assenagon Asset Management
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals